Same-store sales from continuing operations for the year decreased 2.9%, consisting of a 3.9% drop in pharmacy sales and a 0.8% dip in front-end sales.
The retailer said it earned $194 million, or $1.41 a share, in the quarter ended March 3, compared with $269 million, or $1.84 a share, in the year-ago period.
Walgreens Boots Alliance and its predecessor company, Walgreens, have paid a dividend consistently for more than 85 years and have raised that dividend for 42 consecutive years.
The expiration of the waiting period under the HSR Act satisfies one of the conditions to the closing of the merger, which remains subject to other customary closing conditions, including the approval of Rite Aid's stockholders.
Retail Pharmacy USA had second quarter sales of $24.5 billion, an increase of 12.2% over the year-ago quarter. Sales in comparable stores increased 2.4%.
The company entered into a restructuring support agreement with a group of creditors and its private equity sponsor regarding a comprehensive financial restructuring that will position the company for long-term financial health.